ReviewBMC medicine2009
Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review.
Review in BMC medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation.Trials · 2012Trial
- Implementation of an algorithm for predicting exacerbations in telemonitoring: A multimethod study of patients' and clinicians' experiences.International journal of nursing studies advances · 2024Article
- Article
- Article
- Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2016Article
- Article
- Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods.Drugs - real world outcomes · 2015Article
- Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.British journal of clinical pharmacology · 2015Article
- Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations.American journal of physiology. Lung cellular and molecular physiology · 2014Article
- Study of drug utilization pattern for acute exacerbation of chronic obstructive pulmonary disease in patients attending a government hospital in kerala, India.Journal of family medicine and primary care · 2014Article
- Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: a prospective study.Pulmonary medicine · 2014Article
- Chronic obstructive pulmonary disease.Lancet (London, England) · 2012Review
- Exacerbations of chronic obstructive pulmonary disease.The open nursing journal · 2012Article
- Article
- Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis.Paediatric respiratory reviews · 2011Article
- Evaluation of stat orders in a teaching hospital: a chart review.Clinical drug investigation · 2011Article
- Roflumilast.Nature reviews. Drug discovery · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Exacerbations of chronic obstructive pulmonary disease (COPD) are important events in the natural history of this prevalent and devastating condition. This review provides a concise, state of the art summary on prevention and management of exacerbations. Considerable new data underpins evidence in support of many preventative interventions, pharmacological and non-pharmacological, that are now available. Challenges remain in developing new approaches, and delivering those that already exist to the right patient at the right time. Management of an exacerbation remains stepwise according to clinical severity, but there is now additional focus on addressing comorbidities and taking the opportunity at acute events to optimise preventative strategies for the future. Ultimately, exacerbations are heterogeneous events in a heterogeneous disease, and an individualised approach is paramount.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.